Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was founded in 2018 and is based in Nanaimo, Canada.
Australian researchers have published preliminary results findings of first clinical trial of Tilray's (TLRY) GMP-produced products, that it shows a significant improvement in the control of chemotherapy-induced nausea and vomiting. A quarter of the patients taking medicinal cannabis experienced no vomiting and nausea, compared to 14 percent of people who...
According to this CBD Oil Extract Market report, the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has influence on the market and Industry as a whole and also affecting the sales,
GAINERS: CordovaCann (OTCQB: LVRLF ) shares closed up 29.03% at $0.20 Flower One Hldgs (OTCQX: FLOOF ) shares closed up 16.65% at $0.14 Aurora Cannabis (NYSE: ACB ) shares closed up 15.64% at $7.32 Cresco Labs (OTCQX: CRLBF ) shares closed up 8.8% at $5.98 Tilray (NASDAQ: TLRY ) shares closed up 7.3% at $5.37 Nextleaf Solutions (OTCQB: OILFF ) shares closed up 7% at $0.16 Cannabics Pharmaceuticals (OTCQB: CNBX ) shares closed up 6.45% at $0.18 MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 6.25% at $0.02 Marrone Bio Innovations (NASDAQ: Full story available on Benzinga.com